We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Sirolimus Coated Catheter Clears Dysfunctional Hemodialysis Shunts

By HospiMedica International staff writers
Posted on 12 Sep 2019
Print article
Image: A uniquely coated catheter clears blocked dialysis access points (Photo courtesy of Concept Medical).
Image: A uniquely coated catheter clears blocked dialysis access points (Photo courtesy of Concept Medical).
A novel balloon catheter treats stenotic arteriovenous fistula (AVF) or arteriovenous graft (AVG) vascular access anastomosis.

The Concept Medical (Tampa, FL, USA) MagicTouch AVF Sirolimus coated balloon catheter is indicated for use in percutaneous transluminal angioplasty (PTA) of stenotic lesions of dysfunctional native AVF or AVG that are 4-12 mm in diameter and up to 100 mm in length. Features include a design that combines flexibility and strength, for extended reach and resistance to kinking; a tripod reinforced shaft construction that enables more axial strength and higher pushability; a low profile balloon; and perfect tip adherence to the guide wire, which eliminates the fish mouth effect.

Thanks to exclusive Nanolute technology, Sirolimus is converted into sub-micron sized particles inside encapsulated carriers, which are sprayed onto the balloon surface, providing a uniform coating. The result is reduced in-transit loss of the drug, increased bioavailability and biocompatibility, and faster uptake in tissue on delivery. Upon inflation at the target site, the nano-carrier with Sirolimus drug inside gets transferred to the vessel wall. Due to pH variation, the drug carrier mimics body lipids, liberating the sub-micron sized Sirolimus drug particles to penetrate the deepest layer of the vessel.

“Our preliminary data using the Magic Touch Sirolimus coated balloon at the graft-vein junction of blocked AV grafts, and within native AV fistulas, have been promising to date, with an excellent safety profile and patient acceptability,” said consultant vascular and endovascular Surgeon Tjun Yip Tang, MD, of Singapore General Hospital. “Technical and procedural success has been 100%. We have yet to repeat intervention in those who have had MagicTouch AVF elution to their native fistula, but the follow-up is still early, but we are highly encouraged by this initial pilot data.”

An AVF is the most recommended access for kidney disease patients undergoing dialysis, created by connecting a patient's vein and artery to form a long-lasting site through which blood can be removed and returned. Alternatively, in patients who are unsuitable for a fistula, an AVG--a plastic conduit between an artery and a vein--may be used.

Related Links:
Concept Medical

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Computerized Spirometer
DatospirAira

Print article

Channels

Surgical Techniques

view channel
Image: The device\'s LEDs light up in several colors, allowing surgeons to see which areas they need to operate on (Photo courtesy of UC San Diego)

Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons

During brain surgery, neurosurgeons need to identify and preserve regions responsible for critical functions while removing harmful tissue. Traditionally, neurosurgeons rely on a team of electrophysiologists,... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more